热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Ultra-LEAF™ Purified anti-mouse CD28 Antibod
产品名称：
Ultra-LEAF™ Purified anti-mouse CD28 Antibod
产品类别：
抗体
产品编号：
102115
产品应用：
102115
[价格]
规格 价格 库存
100?g ￥ 1600 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Syrian Hamster
Immunogen
C57BL/6 mouse T-cell lymphoma EL-4
Formulation
0.2 ?m filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxin level is <0.01 EU/?g of the protein (<0.001 ng/?g of the protein) as determined by the LAL test.
Preparation
The Ultra-LEAF? (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
Concentration
The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF? solution contains no preservative; handle under aseptic conditions.
Application

FC - Quality tested
IP, IHC-F, Costim, Block - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per million cells in 100 ?l volume or 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro costimulation of T and NK cells1, in vitro blocking of allogeneic mixed leukocyte response and inhibition of MHC-unrestricted CTL cytotoxicity3,4, in vitro induction of thymocyte differentiation2,5-9,11, and immunohistochemical staining of acetone-fixed frozen sections. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) (Cat. No. 102116).

Additional Product Notes

Get a 50% discount on this product when purchased in our Activation Bundles. Restrictions apply. Learn more…

Application References

(PubMed link indicates BioLegend citation)
  1. Gross JA, et al. 1992. J. Immunol. 149:380. (IP, Costim)
  2. Cibotti R, et al. 1997. Immunity 6:245. (Costim)
  3. Masten BJ, et al. 1997. Am. J. Respir. Cell Mol. Biol. 16:335. (Block)
  4. Nishio M, et al. 1996. J. Immunol. 157:4347. (Block)
  5. Zhang N and He Y-W, 2005. J. Exp. Med. 202:395. (Costim)
  6. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Costim)
  7. Perchonock CE, et al. 2006. Mol Cell Biol. 26(16):6005. (Costim)
  8. Wang W, et al. 2007. J. Immunol. 178:4885. (Costim)
  9. Pua HH, et al. 2007. J. Exp. Med. 204:25. (Costim)
  10. Perchonock CE, et al. 2007. J. Immunol. 179:1768.
  11. Barbi J, et al. 2007. Blood 110:2215.
  12. Milpied P, et al. 2011. Blood 118:2993. PubMed
  13. Cunningham NR, et al. 2011. Int Immunol. 23:693. PubMed
  14. Crispin JC, et al. 2012. J. Immunol. 188:3567. PubMed
  15. Li CR, et al. 2014. J Immunol. 192:1425. PubMed
  16. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
Product Citations
  1. Mammadli M, et al. 2021. Clin Transl Med. 11:e625. PubMed
  2. Jairaman A, et al. 2021. Bio Protoc. 11:e4170. PubMed
  3. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  4. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  5. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  6. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  7. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  8. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  9. Gkountidi AO, et al. 2021. Cancer Immunol Res. 9:748. PubMed
  10. Zhao X, et al. 2021. Int J Oral Sci. 13:31. PubMed
  11. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  12. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  13. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  14. Saito S, et al. 2020. Nutrients. 12:. PubMed
  15. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  16. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  17. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  18. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  19. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  20. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  21. Montes de Oca M, et al. 2020. PLoS Pathog. 16:e1008994. PubMed
  22. Hoover DB, et al. 2020. Int Immunopharmacol. 106359:81. PubMed
  23. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  24. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  25. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  26. Mammadli M, et al. 2021. Cancers (Basel). 13:. PubMed
  27. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  28. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  29. Gudgeon N, et al. 2022. Cell Rep. 40:111193. PubMed
  30. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  31. Herrera FG, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  32. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  33. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  34. Saragovi A, et al. 2020. Elife. 9:00. PubMed
  35. Wu J et al. 2019. Immunity. 50(5):1218-1231 . PubMed
  36. Kanno T, et al. 2022. Front Immunol. 13:904875. PubMed
  37. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  38. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  39. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  40. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  41. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  42. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  43. Liu J, et al. 2020. Nat Commun. 11:6396. PubMed
  44. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  45. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  46. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  47. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  48. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  49. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  50. He Y, et al. 2019. JCI Insight. 4:e130416. PubMed
  51. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  52. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  53. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  54. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  55. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  56. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  57. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  58. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  59. Kumar V, et al. 2022. JACC Basic Transl Sci. 7:1038. PubMed
  60. Xu L, et al. 2022. Nat Commun. 13:6881. PubMed
  61. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  62. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  63. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  64. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  65. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  66. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  67. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
RRID
AB_11150408 (BioLegend Cat. No. 102115) AB_11147170 (BioLegend Cat. No. 102116) AB_2810330 (BioLegend Cat. No. 102121) AB_2810331 (BioLegend Cat. No. 102122) AB_2810332 (BioLegend Cat. No. 102131) AB_2810333 (BioLegend Cat. No. 102132)
Disclaimer

This product may be used for research purposes only. It is not licensed for resale and may only be used by the buyer. This product may not be used and is not licensed for clinical assays where the results of such assays are provided as a diagnostic service. If a diagnostic or therapeutic use is anticipated then a license must be requested from the University of California. The availability of such diagnostic and therapeutic use license(s) cannot be guaranteed from the University of California.

Antigen Details

Structure
Ig superfamily, 44 kD
Distribution

Thymocytes, CD4+, CD8+ peripheral T cells, NK cells

Function
Costimulates T and NK cells
Ligand/Receptor
CD80 (B7-1), CD86 (B7-2)
Cell Type
NK cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Lenschow DJ, et al. 1996. Annu. Rev. Immunol. 14:233.
3. Gross JA, et al. 1992. J. Immunol. 149:380.

Gene ID
12487 View all products for this Gene ID
UniProt
View information about CD28 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线